Abstract:Background and objective: Noninvasive non-alcoholic steatohepatitis (NASH) assessment is a clinical challenge to the management of non-alcoholic fatty liver disease. We aim to develop diagnostic models based on sequential ultrasound molecular imaging (USMI) for the noninvasive identification of NASH in mouse models. Methods: Animal experiments were approved by the Animal Ethics Committee of South China Agricultural University. Forty-nine C57BL/6 mice were divided into normal control, non-alcoholic fatty liver, NASH, and hepatitis groups. Sequential USMI was implemented using CD36-targeted microbubbles (MBs-CD36) and intercellular adhesion molecule-1 (ICAM-1)-targeted microbubbles (MBs-ICAM-1) to visualize hepatic steatosis and inflammation. The targeting signal of USMI was quantified as the normalized intensity difference (NID) with the destruction-replenishment method. Correlation analysis was conducted between the NID-MBs-CD36 and pathological steatosis score and between the NID-MBsICAM-1 and pathological inflammation score. Finally, diagnostic models combining NID-MBs-CD36 with NID-MBs-ICAM-1 were established for NASH diagnosis. Results: MBs-CD36 and MBs-ICAM-1 were successfully prepared and used for sequential USMI in all mice. NID-MBs-CD36 values increased with the progression of steatosis, while NID-MBs-ICAM-1 values increased in parallel with the progression of inflammation. A strong positive correlation was identified between NID-MBs-CD36 and pathological steatosis grade (rs = 0.9078, P < 0.0001) and between NID-MBs-ICAM-1 and pathological inflammation grade (rs = 0.9071, P < 0.0001). Among various sequential USMI-based diagnostic models, the serial testing model showed high diagnostic performance in detecting NASH, with 95% sensitivity, 97% specificity, 95% positive predictive values, 97% negative predictive values, and 96% accuracy. Conclusions: Sequential USMI using MBs-CD36 and MBs-ICAM-1 allows noninvasive grading of hepatic steatosis and inflammation. Sequential USMI-based diagnostic models hold great potential in the noninvasive identification of NASH. (c) 2023 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Sequential Ultrasound Molecular Imaging for Noninvasive Identification and Assessment of Non-Alcoholic Steatohepatitis in Mouse Models

Serological Biomarkers Associate Ultrasound Characteristics of Steatohepatitis in Mice with Liver Cancer

Integrating Multi-Omics Reveals Crucial Biomarkers in Non-Alcoholic Fatty Liver Disease

A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease.

Noninvasive Monitoring of Steatotic Liver Disease in Western Diet‐Fed Obese Mice Using Automated Ultrasound and Shear Wave Elastography

Non-invasively Differentiate Non-Alcoholic Steatohepatitis by Visualizing Hepatic Integrin Αvβ3 Expression with a Targeted Molecular Imaging Modality

A Prospective Comparison of Three Ultrasound-Based Techniques in Quantitative Diagnosis of Hepatic Steatosis in NAFLD.

A novel quantitative ultrasound technique for identifying non‐alcoholic steatohepatitis

Effect of Mir-146 Targeted Hdmcp Up Regulation in the Pathogenesis of Nonalcoholic Steatohepatitis

Machine learning model for non-alcoholic steatohepatitis diagnosis based on ultrasound radiomics

Using Intestinal Flora to Distinguish Non-Alcoholic Steatohepatitis from Non-Alcoholic Fatty Liver

Quantitative assessment of hepatic steatosis using label-free multiphoton imaging and customized image processing program

Targeting hepatic miR-221/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice.

Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model

A Multi-Omic Landscape of Steatosis-to-nash Progression

Assessment and integration of multiparametric MRI for liver fibrosis staging in rat non-alcoholic steatohepatitis: Evaluation of diagnostic efficiency and model interpretation

Targeting Hepatic Mir-221/222 for Therapeutic Intervention of Nonalcoholic Steatohepatitis in Mice

Lipidomics Workflow for Analyzing Lipid Profiles Using Multiple Reaction Monitoring (MRM) in Liver Homogenate of Mice with Non-alcoholic Steatohepatitis (NASH)

Intelligent Diagnosis of Non-alcoholic Fatty Liver Disease Based on Multi-modal Ultrasound Features

Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis

The Significance of IL-28B and CK-18 M30 Levels in the Diagnosis of Non-Alcoholic Steatohepatitis in SD Rats.